Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Heplisav-B
Heplisav-B Image


Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Heplisav-B?

Heplisav-B is a vaccine that is used to provide protection against hepatitis B virus infection. It falls under the viral vaccines class of medications and is manufactured by Dynavax Technologies. This vaccine is specifically designed for adults aged 18 years and older. The hepatitis B virus can cause serious liver disease, including chronic infection, liver cirrhosis, and liver cancer. Heplisav-B contains a recombinant DNA technology-derived surface antigen of the hepatitis B virus, which stimulates the body's immune system to produce antibodies against the virus. Compared to other hepatitis B vaccines, Heplisav-B offers a shorter dosing schedule. It is administered in two doses over a month period, whereas traditional hepatitis B vaccines may require three doses over a longer period of time. This can help improve compliance and protection against the virus. As with any medication, Heplisav-B may have potential side effects, although they are generally mild and temporary. Common side effects may include injection site pain, fatigue, headache, and muscle soreness. Serious side effects are rare but may include severe allergic reactions. It is important to discuss with your healthcare provider whether Heplisav-B is the right vaccine for you, taking into consideration your medical history and individual needs.

How to use Heplisav-B?

Heplisav-B is a vaccine medication used to prevent infection caused by the Hepatitis B virus. It is categorized as a viral vaccine and is manufactured by Dynavax Technologies. The vaccine is administered through an intramuscular injection into the upper arm. It is typically given as a two-dose series, with the doses administered one month apart. Each dose consists of 1 mL of the vaccine. It is important to consult a healthcare professional for proper administration instructions and to discuss any specific considerations or individualized dosing schedules that may be applicable. The healthcare professional will determine the appropriate dosage and schedule based on factors such as age, overall health, and previous vaccinations. As with any medication, it is crucial to follow the instructions provided by the healthcare professional or the official prescribing information. This includes not administering more or less of the vaccine than prescribed, adhering to the recommended schedule, and seeking medical advice if there are any concerns or questions.

Heplisav-B is an FDA-approved vaccine used to protect against hepatitis B infection in adults aged 18 years and older. While vaccines are generally considered safe, it's essential to be aware of the potential warnings associated with Heplisav-B. Here are some important warnings: 1. Allergic Reactions: Some individuals may experience allergic reactions, including difficulty breathing, hives, or swelling of the face and throat. If you notice any signs of an allergic reaction after receiving Heplisav-B, seek immediate medical attention. 2. Syncope (Fainting): Fainting can occur following vaccination, particularly in adolescents and adults. It is important to remain seated or lying down for about 15 minutes after receiving the vaccine to reduce the risk of injury from fainting. 3. Moderate to Severe Pain: Pain at the injection site is a common side effect. However, in some cases, individuals may experience moderate to severe pain. Inform your healthcare provider if you have persistent or worsening pain. 4. Immune Disorders: Heplisav-B might be less effective in individuals with certain immune disorders. If you have a weakened immune system or are receiving immunosuppressive therapy, discuss the potential risks and benefits of the vaccine with your healthcare provider. Remember, these are not exhaustive warnings, and it's always crucial to consult with your healthcare provider for a complete list of warnings associated with Heplisav-B and to address any concerns you may have.

Before taking Heplisav-B, it is important to be aware of the following warnings: 1. Allergic Reactions: You should not take Heplisav-B if you have had a severe allergic reaction to any component of the vaccine, including yeast. Signs of an allergic reaction may include difficulty breathing, hives, or swelling of the face, lips, tongue, or throat. Seek immediate medical attention if any of these symptoms occur. 2. Immunocompromised Individuals: Heplisav-B effectiveness may be decreased in individuals with weakened immune systems, such as those with HIV infection or those who are undergoing immunosuppressive therapy. Consult with your healthcare provider to determine if this vaccine is appropriate for you. 3. Fever and Illness: It is recommended to delay Heplisav-B administration in individuals with a fever. If you have a moderate or severe illness, it may be best to wait until you have recovered before receiving the vaccine. 4. Drug Interactions: Inform your healthcare provider about all the medications, supplements, and herbal products you are currently taking. Some medications may interact with Heplisav-B, potentially affecting its effectiveness or causing adverse reactions. 5. Pregnancy and Breastfeeding: The safety of Heplisav-B in pregnant or breastfeeding individuals has not been established. Consult with your healthcare provider to weigh the potential benefits and risks before receiving the vaccine. 6. Side Effects: Common side effects of Heplisav-B include pain at the injection site, fatigue, headache, muscle pain, joint pain, and nausea. These side effects are generally mild and resolve on their own. Remember, always discuss your medical history, current medications, and any concerns with your healthcare provider before starting any new medication, including Heplisav-B. They are best equipped to advise you on the proper usage and potential risks associated with the vaccine.

Heplisav-B is a hepatitis B vaccine that helps protect against the hepatitis B virus. As with any medication, there can be potential side effects. Common side effects of Heplisav-B include pain and redness at the injection site, fatigue, headache, and muscle aches. These symptoms are generally mild and temporary. In rare cases, more serious side effects can occur, although they are very uncommon. These may include symptoms such as severe allergic reactions, difficulty breathing, dizziness, rapid heartbeat, or swollen face, lips, tongue, or throat. If any of these symptoms occur after receiving Heplisav-B, immediate medical attention should be sought. It is important to discuss your medical history and any potential allergies with your healthcare provider before receiving this vaccine. They will be able to provide more specific information regarding potential side effects and determine if Heplisav-B is the right choice for you.

Heplisav-B is a viral vaccine that helps protect against infection caused by the hepatitis B virus. It is manufactured by Dynavax Technologies. The main active ingredient in Heplisav-B is a recombinant hepatitis B surface antigen called HBsAg. This antigen is produced through a biotechnology process. In addition to the HBsAg antigen, Heplisav-B also contains other inactive ingredients. These include: 1. Aluminum hydroxide: This is commonly used as an adjuvant in vaccines to enhance the immune response. 2. 3-O-desacyl-4'-monophosphoryl lipid A (MPL): This component is a toll-like receptor 4 (TLR4) agonist, which helps stimulate the immune system. 3. Phosphate buffer: It serves as a stabilizing agent to maintain the pH of the vaccine. These ingredients work together to stimulate the immune system to produce a protective response against the hepatitis B virus. It is important to consult with a healthcare professional or refer to the package insert for complete information on the specific ingredients and their concentrations in Heplisav-B.

Heplisav-B is a viral vaccine that is used to prevent hepatitis B infection in adults. When it comes to storage, it is important to handle Heplisav-B properly to maintain its effectiveness. Heplisav-B should be stored in the refrigerator between 2°C and 8°C (36°F and 46°F). It is crucial to keep the vaccine refrigerated at all times, even during transportation or when it is being administered. Freezing the vaccine should be avoided, as it can cause damage and reduce its effectiveness. If Heplisav-B is accidentally frozen, it should not be used and must be discarded. Additionally, the vaccine should be protected from light and should be kept in its original packaging until ready for use. It is also important to check the expiration date on the packaging before using the vaccine. Expired vaccines should never be used, as they may not provide adequate protection against hepatitis B. Proper storage and handling of Heplisav-B is essential to ensure its efficacy and maximize its ability to protect against hepatitis B infection.